SCHEMBL276569

SCHEMBL276569

O=C(O)C(O)c1cccc(C(O)C(=O)O)c1

nearest known ligand 0.73

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.73
MAPK1 P28482 1/20 0.73
BLM P54132 2/20 0.48
NPSR1 Q6W5P4 1/20 0.48
TSHR P16473 1/20 0.48
SRC P12931 2/20 0.48
CYP2D6 P10635 1/20 0.48
CES2 O00748 3/20 0.46
CES1 P23141 2/20 0.46
PGK1 P00558 1/20 0.46
PGK2 P07205 1/20 0.46
POLB P06746 1/20 0.45
PKM P14618 1/20 0.45
PTPN1 P18031 1/20 0.45
PTPN7 P35236 1/20 0.45
KMT2A Q03164 1/20 0.45
ESR2 Q92731 1/20 0.45
L3MBTL1 Q9Y468 1/20 0.45
CPN1 P15169 1/20 0.44
CPB2 Q96IY4 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11443180 0.89 LMNA (0.59) LMNAMAPK1BLMNPSR1TSHR
SCHEMBL23972853 0.89 LMNA (0.59) LMNAMAPK1BLMNPSR1TSHR
SCHEMBL1094333 0.87 LMNA (0.61) LMNAMAPK1BLMNPSR1TSHR
SCHEMBL29690043 0.87 LMNA (0.61) LMNAMAPK1BLMNPSR1TSHR
SCHEMBL2453388 0.87 LMNA (0.61) LMNAMAPK1BLMNPSR1TSHR
SCHEMBL1095105 0.87 LMNA (0.61) LMNAMAPK1BLMNPSR1TSHR
SCHEMBL6402095 0.87 LMNA (0.61) LMNAMAPK1BLMNPSR1TSHR
SCHEMBL30573230 0.87 LMNA (0.61) LMNAMAPK1BLMNPSR1TSHR
SCHEMBL1095104 0.87 LMNA (0.61) LMNAMAPK1BLMNPSR1TSHR
SCHEMBL1840382 0.87 LMNA (0.61) LMNAMAPK1BLMNPSR1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 248 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220325035-A1 POLYESTER, POLYESTERAMIDE, AND POLYAMIDE COMPOSITIONS IYER ANANTH V (US) 2022-10-13 US claimed
US-12625441-B2 Electrostatic charge image developing toner and image forming method Konica Minolta, Inc. (JP) 2026-05-12 US disclosed
US-12623006-B2 Medical instrument TERUMO KABUSHIKI KAISHA (JP) 2026-05-12 US disclosed
US-12554209-B2 Toner particle with amorphous polyester resin HEWLETT-PACKARD DEVELOPMENT COMPANY, L.P. (US) 2026-02-17 US disclosed
US-12449742-B2 Toner and method for manufacturing toner CANON KABUSHIKI KAISHA (JP) 2025-10-21 US disclosed
WO-2025216738-A1 TIN OXIDE-POLYMER COMPOSITE TONER SURFACE PARTICLES HEWLETT-PACKARD DEVELOPMENT COMPANY, L.P. (US) 2025-10-16 WO disclosed
EP-3926408-B1 IMAGE FORMING METHOD AND IMAGE FORMING SYSTEM KONICA MINOLTA INC (JP) 2025-09-24 EP disclosed
US-12411430-B2 Electrostatic latent image developing toner and electrostatic latent image developing toner set Konica Minolta, Inc. (JP) 2025-09-09 US disclosed
US-12405546-B2 Toner CANON KABUSHIKI KAISHA (JP) 2025-09-02 US disclosed
US-20250243375-A1 PRINTING MATERIAL INCLUDING SALEN COMPOUND HEWLETT-PACKARD DEVELOPMENT COMPANY, L.P. 2025-07-31 US disclosed
US-6110578-A STRUCTURAL UNIT DERIVED FROM HYDROXYCARBOXYLIC ACID, A STRUCTURAL UNIT DERIVED FROM MOLECULAR WEIGHT INCREASING AGENT AND/OR A STRUCTURAL UNIT DERIVED FROM POLYMERIZATION CATALYST DEACTIVATOR. DAINIPPON INK AND CHEMICALS, INC. (JP) 2000-08-29 US disclosed
US-6037384-A POLYLACTONE AND POLYMERIZATION CATALYST DEACTIVATOR; BIODEGRADABLE, STORAGE STABILITY, HEAT RESISTANCE, IMPACT STRENGTH, MOLDABILITY; PACKAGING, INSULATION, CUSHIONS DAINIPPON INK AND CHEMICALS, INC. (JP) 2000-03-14 US disclosed
US-5670084-A Alignment layer material for liquid crystal display devices HOECHST AKTIENGESELLSCHAFT (DE) 1997-09-23 US disclosed
US-5635570-A THERMOPLASTIC MOLDING MATERIALS; HOMOGENEITY, IMPACT STRENGTH SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1997-06-03 US disclosed
US-5543474-A BLEND OF A AROMATIC POLYAMIDEIMIDE COPOLYMER AND A POLYESTER MITSUBISHI GAS COMPANY, INC. (JP) 1996-08-06 US disclosed
EP-0708149-A1 Alignment layer material for liquid crystal display devices HOECHST AKTIENGESELLSCHAFT (DE) 1996-04-24 EP disclosed
EP-0637613-A1 RESIN COMPOSITION MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 1995-02-08 EP disclosed
EP-0282052-B1 POLYPHENYLENE ETHER RESIN COMPOSITION MITSUBISHI PETROCHEMICAL CO., LTD. (JP) 1992-10-14 EP disclosed
US-4879360-A POLYESTER, EPOXIDIZED POLYBUTADIENE MITSUBISHI PETROCHEMICAL CO., LTD. (JP) 1989-11-07 US disclosed
EP-0282052-A2 Polyphenylene ether resin composition MITSUBISHI PETROCHEMICAL CO., LTD. (JP) 1988-09-14 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12625441-B2 Electrostatic charge image developing toner and image forming method EWSR1, AFF4, DYRK2 LMNA 4504/4885MAPK1 2818/4885BLM 3837/4885
US-12623006-B2 Medical instrument MMAB, MIF, CD44 LMNA 3546/4885MAPK1 4048/4885BLM 405/4885
US-12554209-B2 Toner particle with amorphous polyester resin MYD88, MSR1, CD14 LMNA 2620/4885MAPK1 1575/4885BLM 1075/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.